Rising demand for hemodynamic monitoring in critical care and disease treatment is likely to drive the growth of the global hemodynamic monitoring system market. The latest figures indicate an exponential rise in the number of infants suffering from congenital heart diseases (CHDs). Various studies show that more than 40,000 infants in the U.S. are born with CHD every year. This disease can be fatal if not treated on time. Therefore, the rising incidence of CHD in the past few years has increased the demand for the hemodynamic monitoring systems. The global hemodynamic monitoring system market was valued at US$328.7 mn in 2014 and is anticipated to reach US$508.4 mn by the end of 2021, expanding at a CAGR of 6.5% between 2015 and 2021.
Browse Full Global Hemodynamic Monitoring System Market with TOC:http://www.mrrse.com/hemodynamic-monitoring-system-market
Increasing Government Initiatives in Development of Diagnostic Modalities Promote Uptake of Hemodynamic Monitoring Systems
Increasing public and private funding is one of the key drivers in the growth of the global hemodynamic monitoring system market. The private companies and government organizations have started funding hospitals thereby boosting the sales of hemodynamic monitors. To put this in perspective, in the U.S., the National Institutes of Health (NIH) runs the Vascular Interventions/Innovations and Therapeutic Advances Program that promotes the development of therapeutic and diagnostic modalities. This program aids the development of a number of tests for the pulmonary arterial hypertension therapy through the integration of hemodynamic monitoring with advanced software technology.
Other factors propelling the growth of the global hemodynamic monitoring system market are increasing the incidence of respiratory disorders, rising prevalence of lifestyle diseases, growing the geriatric patient population, and growth in the number of people suffering from hypertension and diabetes. However, the risk associated with invasive hemodynamic monitoring such as bleeding, thrombosis, and sepsis can negatively influence the demand for the hemodynamic monitoring systems.
Increasing Adoption of Pulmonary Artery Catheters to Bode Well for Hemodynamic Monitoring System Market
On the basis of device type, the pulmonary artery catheters segment was the leading segment in terms of revenue in 2015 with a share of 35.0% in the overall market. These devices are increasingly finding applications in addressing the cardiac disorders. For instance, rheumatic heart disease in women can cause hemodynamic changes that can result in severe complications in pregnancy, labor, delivery, and postpartum recovery. Therefore, physicians are using pulmonary artery catheter to perform hemodynamic monitoring, which helps in maintaining adequate perfusion pressure.
Technological Advancements in field of Hemodynamic Monitoring to Put North America in Most Prominent Position
Geographically, the global hemodynamic monitoring system market is segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. By revenue, North America was the leading segment in 2015 and accounted for a share of 30.5% in the global hemodynamic monitoring system market. The growth of this region can be attributed to government and private sector initiatives and technological advancements. In addition, the rising prevalence of diabetes and growing geriatric population will augment the growth of the regional market.
Browse the full Press Release of Global Hemodynamic Monitoring System Market at http://www.mrrse.com/global-hemodynamic-monitoring-system-market
Rapid Infrastructural Development in Asia Pacific to Benefit Sales of Hemodynamic Monitoring Systems
Asia Pacific will be the fastest growing segment between 2014 and 2021. The rapid growth in the healthcare infrastructure of countries such as India, China, and Japan will augur well for the growth of the regional hemodynamic monitoring system market. Other factors such as increasing prevalence of chronic obstructive pulmonary diseases and diabetes will fuel the growth of the market in the APAC region.
Some of the key players in the global hemodynamic monitoring system market are ICU Medical Inc., PULSION Medical Systems SE, Edwards Lifesciences Corporation, LiDCO Group Plc, and Teleflex Incorporated.